Relmada Therapeutics, Inc. (RLMD) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$5.8
Day's range
$7.41

Relmada Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
JANUS HENDERSON GROUP PLC 02/17/2026 7.27 M $35.04 M   100.00% 21.90%
02/17/2026 6.70 M $32.36 M   100.00% 20.19%
ADAGE CAPITAL PARTNERS GP, L.L.C. 02/17/2026 4.27 M $20.62 M   100.00% 12.86%
02/13/2026 4.09 M $19.74 M   100.00% 12.31%
MARSHALL WACE, LLP 02/13/2026 3.19 M $15.41 M   1,072.44% 9.61%
IKARIAN CAPITAL, LLC 02/18/2026 3.07 M $14.82 M   66.48% 9.24%
ORBIMED ADVISORS LLC 02/17/2026 2.61 M $12.61 M   100.00% 7.87%
AMERIPRISE FINANCIAL INC 02/17/2026 1.92 M $9.27 M   100.00% 5.78%
DRIEHAUS CAPITAL MANAGEMENT LLC 02/17/2026 1.88 M $9.08 M   154.05% 5.66%
MILLENNIUM MANAGEMENT LLC 02/17/2026 1.67 M $8.08 M   100.00% 5.04%
BRAIDWELL LP 02/17/2026 1.58 M $7.64 M   100.00% 4.77%
BLACKROCK, INC. 02/12/2026 1.27 M $6.12 M   149.51% 3.82%
VANGUARD GROUP INC 01/29/2026 1.20 M $5.81 M   187.47% 3.63%
OPALEYE MANAGEMENT INC. 04/13/2026 935.00 K $4.52 M   100.00% 2.82%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 854.93 K $4.13 M   188.62% 2.58%
BOOTHBAY FUND MANAGEMENT, LLC 02/17/2026 835.30 K $4.03 M   20.49% 2.52%
CI PRIVATE WEALTH, LLC 03/09/2026 719.58 K $3.44 M   248.18% 2.17%
TWO SIGMA INVESTMENTS, LP 02/17/2026 572.84 K $2.77 M   229.95% 1.73%
BALYASNY ASSET MANAGEMENT L.P. 02/17/2026 547.85 K $2.65 M   100.00% 1.65%
ACADIAN ASSET MANAGEMENT LLC 02/10/2026 526.72 K $2.54 M   -9.58% 1.59%
DIADEMA PARTNERS LP 02/17/2026 389.40 K $1.88 M   100.00% 1.17%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 385.94 K $1.86 M   178.81% 1.16%
STATE STREET CORP 02/13/2026 320.82 K $1.55 M   215.09% 0.97%
ADVISORSHARES INVESTMENTS LLC 02/10/2026 319.51 K $1.54 M   -20.81% 0.96%
JANE STREET GROUP, LLC 02/12/2026 271.11 K $1.31 M   216.47% 0.82%
PARSONS CAPITAL MANAGEMENT INC/RI 01/13/2026 263.00 K $1.27 M   61.02% 0.79%
PERSISTENT ASSET PARTNERS LTD 02/17/2026 231.12 K $1.12 M   100.00% 0.70%
DEUTSCHE BANK AG\ 02/11/2026 224.85 K $1.09 M   0.00% 0.68%
POINT72 ASSET MANAGEMENT, L.P. 02/17/2026 187.38 K $905.03 K   100.00% 0.56%
RENAISSANCE TECHNOLOGIES LLC 02/12/2026 185.00 K $893.55 K   9.02% 0.56%
NORTHERN TRUST CORP 02/17/2026 165.45 K $799.14 K   180.32% 0.50%
EAM INVESTORS, LLC 02/12/2026 162.55 K $785.13 K   100.00% 0.49%
TWO SIGMA ADVISERS, LP 02/17/2026 162.20 K $783.43 K   318.04% 0.49%
QUBE RESEARCH & TECHNOLOGIES LTD 02/17/2026 155.53 K $751.21 K   100.00% 0.47%
04/02/2026 154.11 K $744.35 K   100.00% 0.46%
GOLDMAN SACHS GROUP INC 03/25/2026 145.00 K $700.35 K   100.00% 0.44%
RBF CAPITAL, LLC 02/17/2026 140.00 K $676.20 K   -14.25% 0.42%
SQUAREPOINT OPS LLC 02/13/2026 138.23 K $667.67 K   100.00% 0.42%
MGO ONE SEVEN LLC 02/03/2026 100.00 K $483.00 K   0.00% 0.30%
SEI INVESTMENTS CO 02/13/2026 98.97 K $478.00 K   100.00% 0.30%
CAPTION MANAGEMENT, LLC 02/17/2026 73.60 K $355.49 K   100.00% 0.22%
EXODUSPOINT CAPITAL MANAGEMENT, LP 02/17/2026 68.88 K $332.71 K   100.00% 0.21%
OMERS ADMINISTRATION CORP 02/13/2026 65.90 K $318.30 K   100.00% 0.20%
MORGAN STANLEY 02/13/2026 62.36 K $301.19 K   5,901.64% 0.19%
BARCLAYS PLC 02/13/2026 60.00 K $289.80 K   500.00% 0.18%
LMR PARTNERS LLP 02/17/2026 55.60 K $268.55 K   0.00% 0.17%
QUADRATURE CAPITAL LTD 02/17/2026 53.44 K $258.14 K   100.00% 0.16%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 53.08 K $256.38 K   100.00% 0.16%
APRICUS WEALTH, LLC 01/15/2026 47.46 K $229.24 K   0.00% 0.14%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 47.20 K $227.98 K   -28.48% 0.14%

Relmada Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 96 institutional investors and hedge funds held shares of Relmada Therapeutics Inc. The most heavily invested institutionals were:

PARSONS CAPITAL MANAGEMENT INC/RI: 352,500

AdvisorShares Investments LLC: 295,872

UBS Group AG: 126,672

Hillsdale Investment Management Inc.: 53,600

apricus wealth, LLC: 47,462

Robertson Stephens Wealth Management, LLC: 25,000

153.40% of Relmada Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 41.98 M shares in the last 24 months. This purchase volume represents approximately $301.00 M in transactions.